RGX-121

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
CAMPSIITE™ RGX-121 Gene Therapy in Subjects With MPS II (Hunter Syndrome)NCT03566043RGNXPhase 2, Phase 3Active not recruiting2023-11-27Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.